Home » Topics » Regulatory » Patents

Patents
RSS

Shionogi & Co. patents MGAT2 inhibitors

July 21, 2017

Vitae Pharmaceuticals discloses menin/MLL interaction inhibitors

July 21, 2017

Chiesi Farmaceutici presents MAPK inhibitors

July 20, 2017

Gruenenthal discloses PDE4B inhibitors

July 20, 2017

Mission Therapeutics divulges deubiquitylating enzyme inhibitors

July 20, 2017

Bayer Pharma patents IRAK-4 inhibitors

July 20, 2017

Chiesi Farmaceutici patents MAPK inhibitors

July 19, 2017

Dompe Farmaceutici divulges TRPM8 antagonists

July 19, 2017

Gruenenthal identifies PDE4B inhibitors

July 19, 2017

Roche and Genentech present IRAK-4 inhibitors

July 19, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...